SCHEDULE 13D/A

ARS Pharmaceuticals Inc

Common Stock, par value $0.0001 per share · CUSIP: 82835W108

Event date: 2025-03-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Deerfield Mgmt III, L.P.Reported CIK 0001610540

  Shares: 5,257,329.00 · Class: 5.36%

• Deerfield Private Design Fund III, L.P.Reported CIK 0001603333

  Shares: 5,257,329.00 · Class: 5.36%

• Deerfield Mgmt IV, L.P.Reported CIK 0001713467

  Shares: 5,257,328.00 · Class: 5.36%

• Deerfield Private Design Fund IV, L.P.Reported CIK 0001680307

  Shares: 5,257,328.00 · Class: 5.36%

• Deerfield Management Company, L.P.Reported CIK 0001009258

  Shares: 10,514,657.00 · Class: 10.72%

• James E. FlynnReported CIK 0001352546

  Shares: 10,514,657.00 · Class: 10.72%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.